Shortlisted design teams announced for proposed new joint eye care, research and education facility

The RIBA (Royal Institute of British Architects), Moorfields Eye Hospital NHS Foundation Trust, UCL (University College London) and Moorfields Eye Charity are pleased to announce the teams shortlisted to design a new joint eye care, research and education facility for Moorfields Eye Hospital and UCL Institute of Ophthalmology.

This follows the first phase of the ‘Competitive Procedure with Negotiation’ to select a multi-disciplinary design team.

The shortlisted teams are:

  • AECOM Ltd with White Arkitekter AB & Penoyre and Prasad
  • Bennetts Associates with Reiach & Hall, Buro Happold Engineering & Gustafson Porter + Bowman
  • Hopkins Architects with Arup & Todd Longstaffe-Gowan Ltd
  • Rogers Stirk Harbour + Partners with Stantec, Arup, Gillespies, Speirs + Major & T Projects
  • Ryder Architecture Ltd with Hawkins\Brown Architects, Spacehub Design Limited, Hoare Lea LLP, Rider Levett Bucknall UK Ltd & Ramboll UK Ltd

The proposed new facility will be flexible and modern, bringing together eye care, research and education for the first time, while being focused on patients and attracting and retaining the best ophthalmic scientists, educators and clinicians.

Kieran McDaid, director of capital estates and major projects at Moorfields Eye Hospital said: “This marks an important and exciting stage of the project, as we can now start to visualise what this new, innovative and modern facility could look like. The joint partners were very pleased by the quality and innovation presented in the submissions of the shortlisted teams.”

“We are excited to see the preliminary designs proposals that each shortlisted team will submit for the next stage.”

“We’d like to extend our thanks to all teams who submitted applications to design this new, world-class facility.”

Patients, staff and other stakeholders will have the opportunity to review and provide their feedback on the preliminary design proposals at an exhibition in late November 2018. This feedback will inform the evaluation panel.

The shortlisted teams will now start on their design proposals and the winner will be announced in December 2018.

For more information please contact: Julia Davies (

The Royal Institute of British Architects (RIBA) is a global professional membership body that serves its members and society in order to deliver better buildings and places, stronger communities and a sustainable environment. Follow @RIBA on Twitter for regular updates

Moorfields Eye Hospital NHS Foundation Trust is a world-leading provider of eye care services in the UK. We provide a wide range of clinical services, caring for patients in over 30 locations in and around London to provide expert treatment closer to patients’ homes. We also operate commercial divisions that provide care to private patients in both London and the Middle East. With our academic partner, the UCL Institute of Ophthalmology, we are recognised as a leading centre of excellence in eye research and education. To find out more go to:

UCL Institute of Ophthalmology is one of a number of specialised biomedical research centres within UCL. We conduct cutting-edge science, attracting research workers of the highest international calibre. In recognition of the Institute’s international standing, the most recent HEFCE (Higher Education Funding Council for England) Research Evaluation Framework exercise confirmed the outstanding quality of research carried out at the Institute. According to the 2017 Centre for World University Rankings, UCL is the best place in the world to study ophthalmology. For further information go to:

Moorfields Eye Charity supports the work of Moorfields Eye Hospital and its research partner, the UCL Institute of Ophthalmology, making a difference for patients at the hospital and for people with sight problems around the world. It provides grants and raises money to help the hospital provide the best possible care for its patients, educate the researchers and clinicians of tomorrow and support leading-edge research that aims to develop new treatments for blinding diseases. To find out more go to:

Was this information useful? Please rate the page.